| abstract |
(57) [Summary]nThe present invention relates generally to methods of stimulating phagocytosis, thereby combating infection and / or modulating immune complex disease. In particular, a method of modulating the number and type of Fc receptors present in cells that normally have Fc receptors, including mononuclear cells and macrophages, and cells that do not normally have Fc receptors, such as fibroblasts, and It relates to compounds and compositions suitable for use in such methods. |